Connor, Clark & Lunn Investment Management (CC&L)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $2.35M | Sell |
|
|||||
|
2023
Q2 | $1.69M | Buy |
|
|||||
|
2023
Q1 | $1.95M | Buy |
|
|||||
|
2022
Q4 | $1.76M | Buy |
|
|||||
|
2022
Q3 | $1.9M | Buy |
|
|||||
|
2022
Q2 | $1.35M | Sell |
|
|||||
|
2022
Q1 | $1.74M | Sell |
|
|||||
|
2021
Q4 | $1.92M | Sell |
|
|||||
|
2021
Q3 | $1.75M | Sell |
|
|||||
|
2021
Q2 | $2.4M | Buy |
|
|||||
|
2021
Q1 | $2.56M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $671K | Buy |
|